CN103787970A - Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method - Google Patents
Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method Download PDFInfo
- Publication number
- CN103787970A CN103787970A CN201410014913.9A CN201410014913A CN103787970A CN 103787970 A CN103787970 A CN 103787970A CN 201410014913 A CN201410014913 A CN 201410014913A CN 103787970 A CN103787970 A CN 103787970A
- Authority
- CN
- China
- Prior art keywords
- difluoro
- diketone
- reaction
- temperature
- benzisothiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C(C)(*)C(C([O+])=O)=C(C)C)N Chemical compound CC(C(C)(*)C(C([O+])=O)=C(C)C)N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/08—Aza-anthracenes
Abstract
The invention belongs to the field of medicinal chemistry, and discloses a technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone (I) employing a one-pot method. 6,9-difluoro benzisothiazol-5,10-diketone is an important midbody for pixantrone synthesis, and pixantrone is a new aza-anthraquinone drug, and used for treating multiple recurrent or intractable non-hodgkin lymphoma. The technology is simple in operation, low in cost and beneficial to large-scale synthesis.
Description
Technical field
The invention belongs to pharmaceutical chemistry field, be specifically related to a China fir fine jade intermediate 6,9-difluoro benzisoquinoline-5, the synthetic technology of 10-diketone.
Background technology
China fir fine jade is a kind of new naphthazin(e) quinones medicine, is used for the treatment of the Aggressive Non-Hodgkin's of many recurrents or refractory, at present in the clinical study stage three phases.It both can reduce the cardiac toxic that anthracene nucleus medicament is relevant, can not reduce again anticancer therapeutic, was with a wide range of applications.
6,9-difluoro benzisoquinoline-5,10-diketone is a synthetic important intermediate of China fir fine jade, now only has a kind of disclosed synthetic route (CN1282738A, CN1145028, EP0503537A1).Reaction formula is as follows:
This technique obtains target product through three-step reaction, and aftertreatment is loaded down with trivial details, and cost is higher, is unfavorable for suitability for industrialized production.
Summary of the invention
In order to overcome the defect existing in technique scheme, the invention discloses one and treat different things alike legal system for 6,9-difluoro benzisoquinoline-5, the technique of 10-diketone, reaction scheme is as follows:
Concrete operation step is: 3,4-pyridine dicarboxylic acid joins in oleum, in 45-55 ℃ of stirring 2-3 h, slowly drip difluorobenzene, dropwise rear rising temperature to 80-90 ℃ of reaction 2-4 h, continue to increase the temperature to 135-145 ℃ of reaction 2-4 h and stop heating, be cooled to room temperature, reaction solution is slowly poured in frozen water, in process, temperature control is lower than 25 ℃, regulate pH to 1-2, filter and obtain target product.
The feed ratio (mass ratio) of its Raw is 3,4-pyridine dicarboxylic acid: to difluorobenzene: oleum=1:6.5 ~ 7.0:3.5 ~ 4.2.
?
embodiment:
Following instance is used for illustrating the present invention, is not limited to the present invention, all any modifications of doing within principle of the present invention and spirit, is equal to and replaces and improvement etc., within being all just included in protection scope of the present invention.
?
Example one:
In the reaction vessel of 250 mL, add 20% oleum 40 mL, add 3,4-pyridine dicarboxylic acid 20 g, at 50 ℃, heated and stirred is reacted 2 h, temperature is elevated to 90 ℃, stir and lower slowly drip difluorobenzene 123 mL, heated and stirred is reacted 2.5 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 3 h, reaction mixture is cooled to room temperature, slowly pours in 500 mL frozen water, with 40%NaOH adjusting pH to 1, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 18.2 g, and yield is 62%.
Mp.:197.0-199.0?℃。
1H?NMR(CDCl
3):9.54(s,1H),9.12(d,1H),8.03(d,1H),7.57(m,2H)
Example two:
In there-necked flask, add 20% oleum 176 mL, add 3,4-pyridine dicarboxylic acid 100 g, at 48 ℃, heated and stirred is reacted 2.5 h, temperature is elevated to 89 ℃, stir and lower slowly drip difluorobenzene 586 mL, heated and stirred is reacted 3 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 3.5 h, reaction mixture is cooled to room temperature, slowly pours in 2.5 L frozen water, with 40%NaOH adjusting pH to 2, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 82.2g, and yield is 56%.
Mp:197.5-199.9?℃。
Example three:
In the reaction vessel of 3 L, add 20% oleum 633 mL, add 3,4-pyridine dicarboxylic acid 300 g, at 52 ℃, heated and stirred is reacted 2 h, temperature is elevated to 91 ℃, stir and lower slowly drip difluorobenzene 1.9 L, heated and stirred is reacted 3 h, and normal pressure steams unnecessary to difluorobenzene, increase the temperature to about 140 ℃ reaction 4 h, the cooling reaction mixture room temperature that is cooled to, slowly pour in 7.5 L frozen water, with 40%NaOH adjusting pH to 2, suction filtration, filter cake frozen water drip washing, in THF, recrystallization obtains yellow solid 135.5 g, and yield is 52%.
Mp:196.5-198.1?℃。
Claims (2)
1. the legal system for the treatment of different things alike is for 6,9-difluoro benzisoquinoline-5, the technique of 10-diketone (I), it is characterized in that: by 3,4-pyridine dicarboxylic acid joins in oleum, stir 2-3 h in 45-55 ℃, slowly drip difluorobenzene, dropwise rear rising temperature to 80-90 ℃ of reaction 2-4 h, continue to increase the temperature to 135-145 ℃ of reaction 2-4 h and stop heating, reaction solution is cooled to room temperature, slowly pour in frozen water, in process, temperature control, lower than 25 ℃, regulates pH to 1-2, filters and obtains target product
2. method according to claim 2, the feed ratio (mass ratio) of raw material is 3,4-pyridine dicarboxylic acid: to difluorobenzene: oleum=1: 6.5 ~ 7.0: 3.5 ~ 4.2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410014913.9A CN103787970A (en) | 2014-01-14 | 2014-01-14 | Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410014913.9A CN103787970A (en) | 2014-01-14 | 2014-01-14 | Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103787970A true CN103787970A (en) | 2014-05-14 |
Family
ID=50664080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410014913.9A Pending CN103787970A (en) | 2014-01-14 | 2014-01-14 | Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103787970A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0503537A1 (en) * | 1991-03-08 | 1992-09-16 | The University Of Vermont | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones |
WO1992015566A1 (en) * | 1991-03-08 | 1992-09-17 | Boehringer Mannheim Italia S.P.A. | Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents |
CN1101046A (en) * | 1992-09-08 | 1995-04-05 | 佛蒙特大学 | 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones |
WO1995024407A1 (en) * | 1994-03-08 | 1995-09-14 | Boehringer Mannheim Italia, S.P.A. | Hetero-annulated indazoles |
CN1145028A (en) * | 1994-03-28 | 1997-03-12 | 泊灵格曼海姆意大利股份公司 | A improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt |
CN1196055A (en) * | 1995-09-13 | 1998-10-14 | 意大利柏林格·曼海姆股份公司 | 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent |
CN101514153A (en) * | 2009-04-13 | 2009-08-26 | 北京阿格蕾雅科技发展有限公司 | Synthesis method for high-purity substituted anthraquinones |
CN102731285A (en) * | 2012-06-28 | 2012-10-17 | 大连理工大学 | Anthraquinone compounds and applications thereof |
-
2014
- 2014-01-14 CN CN201410014913.9A patent/CN103787970A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0503537A1 (en) * | 1991-03-08 | 1992-09-16 | The University Of Vermont | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones |
WO1992015566A1 (en) * | 1991-03-08 | 1992-09-17 | Boehringer Mannheim Italia S.P.A. | Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents |
CN1101046A (en) * | 1992-09-08 | 1995-04-05 | 佛蒙特大学 | 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones |
WO1995024407A1 (en) * | 1994-03-08 | 1995-09-14 | Boehringer Mannheim Italia, S.P.A. | Hetero-annulated indazoles |
CN1145028A (en) * | 1994-03-28 | 1997-03-12 | 泊灵格曼海姆意大利股份公司 | A improved method of synthesis for 6,9-bis[(2-aminoethyl)amino] benzo[g] isoquinoline-5,10-dione and its dimaleate salt |
CN1282738A (en) * | 1994-03-28 | 2001-02-07 | 诺瓦斯制药公司 | Improved method for sgnthesizing 6,9-bis[(2-aminoethyl) amino] benz[g] isoquinoline-5, 10-diketone and its dimaleate |
CN1196055A (en) * | 1995-09-13 | 1998-10-14 | 意大利柏林格·曼海姆股份公司 | 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent |
CN101514153A (en) * | 2009-04-13 | 2009-08-26 | 北京阿格蕾雅科技发展有限公司 | Synthesis method for high-purity substituted anthraquinones |
CN102731285A (en) * | 2012-06-28 | 2012-10-17 | 大连理工大学 | Anthraquinone compounds and applications thereof |
Non-Patent Citations (8)
Title |
---|
A. PAUL KRAPCHO,等: "6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,lO-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,lO-diones:Synthesis and Antitumor Evaluations", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
QIJUN HOU,等: "Liquid-phase cascade acylation/dehydration over various zeolite catalysts to synthesize 2-methylanthraquinone through an efficient one-pot strategy", 《JOURNAL OF CATALYSIS》 * |
Y.L.N. MURTHY,等: "Synthesis of 2-Methoxy 5-nitro9,10-anthraquinone and study of photophysical properties", 《ORIENTAL JOURNAL OF CHEMISTRY》 * |
ZHICHAO ZHANG,等: "An Anthraquinone Scaffold for Putative,Two-Face Bim BH3 α-Helix Mimic", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
朱洪法,等: "《无机化工产品手册》", 31 December 2008, 金盾出版社 * |
赵欣: "蒽醌类靶向抗肿瘤化合物的合成与性质研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
郑卫,等: "具有潜在抗癌活性的米托蒽醌类似物的合成", 《中国抗生素杂志》 * |
马燕如: "大黄酚和大黄酸合成实验室工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104356092B (en) | Preparation method for vortioxetine | |
CN104530044A (en) | Method for synthesizing riociguat | |
CN103483324B (en) | The new preparation process of lapatinibditosylate | |
CN104370808A (en) | Synthesis method of 2,3-dipicolinic acid | |
CN102304116A (en) | Fluorescein compound and preparation method thereof | |
CN101967120A (en) | Preparation method of 2-p-chlorobenzyl pyridine | |
CN103864960A (en) | Preparation method for hydroxypropyl low-melting-point agarose | |
CN104326975A (en) | Preparation method of high-purity milrinone | |
CN103787924A (en) | New purification method of antitumor drug Belinostat | |
CN103787970A (en) | Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method | |
CN103922925B (en) | A kind of production technique of Fenofibric Acid | |
CN104974057B (en) | The preparation method and important intermediate of a kind of bromfenac sodium | |
CN109096091A (en) | The preparation method of cinnamic acid | |
CN104447303A (en) | Preparation technology of carboxybenzaldehyde | |
CN103896858A (en) | Technology for preparing cytosine | |
CN106008436A (en) | Preparation method of alpha crystal form of Iguratimod | |
CN103102271B (en) | Industrialized preparation method of guacetisal and medical application of dry suspension | |
CN106905135A (en) | A kind of preparation method to bromomethyl phenylacetic acid | |
CN104592249B (en) | A kind of preparation method of clopidogrel free alkali | |
CN104356003B (en) | The synthetic method of aromatic series fluoro-containing intermediate m-fluoroaniline | |
CN102924369A (en) | Method for synthesizing 3,5-dibromo-4-iodopyridine by one step | |
CN109206381B (en) | A method for preparing compound intermediate for regulating activity of cannabinoid receptor | |
CN108863773A (en) | The preparation method of 3- methoxy cinnamic acid | |
CN109384708B (en) | Akt inhibitor intermediate SM1 and preparation method thereof | |
CN102199176A (en) | Preparation method for 2-amino-2-deoxy-D-glucose and salt thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140514 |